Centre Radiothérapie de Blois
- Address
- lock Available on a paid plan
Centre Radiothérapie de Blois - Head and Neck Cancer Radiotherapy
The Centre Radiothérapie de Blois is a specialized radiation oncology facility focused on advancing treatment approaches for head and neck malignancies. The center conducts innovative clinical research combining cutting-edge immunotherapy with targeted radiotherapy techniques to optimize patient outcomes while minimizing treatment-related toxicity.
- Combination immunotherapy and radiotherapy for head and neck cancers
- Squamous cell carcinoma of the head and neck treatment protocols
- Targeted radiotherapy approaches with reduced prophylactic irradiation
The center's research emphasizes evaluating novel therapeutic combinations, particularly investigating durvalumab immunotherapy integrated with precision radiotherapy to tumor sites and cervical lymph nodes. Their clinical trials focus on assessing regional control outcomes in patients with T1-T4 N0-N2b squamous cell carcinoma, exploring treatment strategies that target invaded areas while sparing uninvolved nodal regions, representing a more personalized approach to head and neck cancer management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Radiothérapie de Blois
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase II Evaluation of Durvalumab Combined with Radiotherapy in T1-T4 N0-N2b Squamous Cell Carcinoma of the Head and Neck Without Prophylactic Neck Irradiation | Groupe Oncologie Radiotherapie Tete Cou | Phase II | Not Recruiting | Jul 2019 | Mar 2026 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cisplatin | 1 | Unknown | 2018-08-10 | 2018-08-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.